This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Suzuki, K. Articles by Yacoub, M. H. Search for Related Content PubMed PubMed Citation Articles by Suzuki, K. Articles by Yacoub, M. H. Related Collections CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 2000;102:III-359.)
© 2000 American Heart Association, Inc.

Myocardial Protection and Vascular Biology

Development of a Novel Method for Cell Transplantation Through the Coronary Artery

Ken Suzuki, MD, PhD; Nigel J. Brand, PhD; Ryszard T. Smolenski, MD, PhD; Jay Jayakumar, FRCS; Bari Murtuza, MA, FRCS; Magdi H. Yacoub, FRS

From the Department of Cardiothoracic Surgery, National Heart and Lung Institute, Imperial College School of Medicine at the Heart Science Centre, Harefield Hospital, Middlesex, UK.

Correspondence to Professor Sir Magdi H. Yacoub, Department of Cardiothoracic Surgery, Harefield Hospital, Harefield, Middlesex, UB9 6JH, UK. E-mail Ken.Suzuki{at}harefield.nthames.nhs.uk

Background—Cell transplantation is a promising strategy to treat end-stage heart failure. At present, a popular method to deliver cells into the heart is direct intramuscular injection. This method, however, may not be efficient in spreading cells globally into the myocardium. We have developed a novel method for cell transplantation using intracoronary infusion.

Methods and Results—An L6 rat skeletal muscle cell line expressing ß-galactosidase (ß-gal) was generated by gene transfection and clonal selection. These cells (10⁶ in 1 mL medium) were infused into explanted rat hearts through the coronary artery, followed by heterotopic heart transplantation into the abdomen of recipients. Control hearts were infused with cell-free medium. According to ß-gal activity measurements, 5x10⁵ grafted cells per heart existed on day 3, increasing to 5x10⁶ on day 28 in the cell-transplanted hearts. At day 28, discrete loci positively stained for ß-gal were observed throughout the cardiac layers of both left and right coronary territories. Some of them differentiated into ß-gal–positive multinucleated myotubes that aligned with the cardiac fiber axis and integrated into the native myocardium, whereas others formed colonies consisting of undifferentiated myoblasts. Connexin 43, a cardiac gap junction protein, was expressed between grafted cells and native cardiomyocytes. No reduction in cardiac function was observed in a Langendorff perfusion system.

Conclusions—We have developed a unique method for efficient cell transplantation based on intracoronary infusion. This method, potentially applicable in the clinical setting during cardiac surgery, could be useful to globally supply cells to the heart.

Key Words: cells • transplantation • heart failure

This article has been cited by other articles:

				K. Suzuki, B. Murtuza, L. Heslop, J. E. Morgan, R. T. Smolenski, N. Suzuki, T. A. Partridge, and M. H. Yacoub Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 984 - 992. [Abstract] [Full Text] [PDF]

				K. Suzuki, N. J. Brand, S. Allen, M. A. Khan, A. O. Farrell, B. Murtuza, R. E. Oakley, and M. H. Yacoub Overexpression of connexin 43 in skeletal myoblasts: Relevance to cell transplantation to the heart J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 759 - 766. [Abstract] [Full Text] [PDF]